Lund-Malmö
Creatinine-based equation for adults, developed in Sweden
- Biomarkers
- Creatinine
- Validated for
- 18+ years
- Inputs
- Age, Sex, Creatinine
- Reports
- mL/min/1.73 m²
- Published
- 2011
The eGFR guide explains which equation the calculator suggests and indexed and absolute GFR.
Formula
As text: eGFR = exp(X − 0.0158×age + 0.438×ln(age)); Female pCr<150: X=2.50+0.0121×(150−pCr); Female pCr≥150: X=2.50−0.926×ln(pCr/150); Male pCr<180: X=2.56+0.00968×(180−pCr); Male pCr≥180: X=2.56−0.926×ln(pCr/180) [pCr in µmol/L]
Constants
| Symbol | Meaning | Value |
|---|---|---|
X | Piecewise base term (sex- and SCr-dependent) | Female, pCr<150 µmol/L: 2.50 + 0.0121×(150−pCr) Female, pCr≥150 µmol/L: 2.50 − 0.926×ln(pCr/150) Male, pCr<180 µmol/L: 2.56 + 0.00968×(180−pCr) Male, pCr≥180 µmol/L: 2.56 − 0.926×ln(pCr/180) |
−0.0158 | Linear age coefficient | |
0.438 | Logarithmic age coefficient | |
| Serum creatinine (converted to µmol/L internally: ×88.4) (input) | mg/dL | |
Age | Patient age (input) | years |
How it was developed
This 2011 revision of the Lund-Malmö equation was developed by linear regression in the same cohort as the original: 850 consecutive adults (376 women; aged 18–95 years) referred for GFR measurement to Lund and Malmö University Hospitals, Sweden. GFR was measured as plasma iohexol clearance, adjusted to 1.73 m² body surface area.
Clinical notes
- Implements LM Revised, the version without lean body mass
- Built on IDMS-traceable enzymatic and modified Jaffe creatinine assays
Limitations
- Not validated in ethnicities other than Caucasian
- Development excluded dialysis and conditions causing marked muscle wasting
- Overestimates GFR at BMI below 20 kg/m², most in men
References
- Björk J, Grubb A, Sterner G, Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. Scand J Clin Lab Invest. 2011;71(3):232-239. doi:10.3109/00365513.2011.557086
- Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52(6):815-824. doi:10.1515/cclm-2013-0741